Q1 2025 Holdings
Filed 2025-05-15 | 22 holdings | $149.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2025-05-19) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $27.7M | 1,131,501 | 18.5% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $16.8M | 1,516,303 | 11.2% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $14.3M | 3,235,387 | 9.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $13.5M | 2,144,844 | 9.0% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $12.2M | 2,152,252 | 8.1% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $11.7M | 3,940,052 | 7.8% |
| Bicara Therapeutics(BCAX) | COM | 055477103 | $8.4M | 643,382 | 5.6% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $5.5M | 1,279,800 | 3.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $5.4M | 1,971,264 | 3.6% |
| Onkure Therapeutics Inc(OKUR)A | CLASS A COM | 68277Q105 | $5.1M | 1,439,674 | 3.4% |
| Verastem Inc(VSTM)A | COM | 92337C203 | $4.7M | 779,498 | 3.1% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $4.7M | 734,394 | 3.1% |
| Cardif Oncology Inc(CRDF) | COM | 14147L108 | $4.5M | 1,442,308 | 3.0% |
| Optinose Inc(0OP) | COM NEW | 68404V209 | $3.9M | 422,814 | 2.6% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $2.0M | 1,139,363 | 1.4% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $1.8M | 7,310,650 | 1.2% |
| Mural Oncology PLC | COM | G63365103 | $1.6M | 1,269,715 | 1.1% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $1.5M | 590,508 | 1.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $1.4M | 4,032,046 | 0.9% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $1.3M | 803,425 | 0.9% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $1.2M | 785,938 | 0.8% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $822.6K | 405,237 | 0.5% |